Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02278250
Title	An Open-Label Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of M4344 (Formerly VX-803) as a Single Agent and in Combination With Cytotoxic Chemotherapy in Participants With Advanced Solid Tumors
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	EMD Serono Research & Development Institute, Inc.
Indications	Advanced Solid Tumor
Therapies	VX-803 Carboplatin + VX-803
Age Groups:	adult \| senior
Covered Countries	USA \| NLD \| GBR \| ESP